Find a Scientist
- Anesthesiology and Perioperative Medicine
- Cancer Biology and Molecular Medicine
- Cancer Control and Population Sciences
- Cancer Genetics and Epigenetics
- Center for Gene Therapy
- Comparative Medicine
- (-) Computational and Quantitative Medicine
- Diabetes & Cancer Discovery Science
- Diabetes & Cancer Metabolism
- Diabetes, Endocrinology & Metabolism
- Diabetes Complications & Metabolism
- Diabetes Immunology & Theranostics
- Diabetes Translational Research and Cellular Therapeutics
- Diagnostic Radiology
- Hematologic Malignancies
- Hematology & Hematopoietic Cell Transplantation
- Immuno-Oncology
- Integrative Translational Sciences
- Medical Oncology and Therapeutics Research
- Medicine
- Molecular & Cellular Endocrinology
- Molecular Diagnostics and Experimental Therapeutics
- Pathology
- Pediatrics
- Population Sciences
- Radiation Oncology
- Stem Cell Biology & Regenerative Medicine
- Supportive Care Medicine
- Surgery
- Systems Biology
Suzette Blanchard, Ph.D., is a biostatistician and associate research professor in the Division of Biostatistics within the Department of Computational and Quantitative Medicine.
Dr. Branciamore's research interests include (i) investigating the impact of epigenetics on development, disease and evolution, (ii) the application of methods from statistical mechanics and dynamical systems to personalized medicine for the treatment of complex diseases and cancer, and (iii) the
Paul Frankel, Ph.D., is is a scientist in the biostatistics division of the Department of Computational and Quantitative Medicine.
Dr. Gu’s research focus is to integrate multi-omics platforms, advanced analytical approaches, and multiple experimental models to study the heterogeneity of acute leukemias and facilitate the development of more efficacious targeted therapies.
Dr. Lacey studies women’s cancer risks and outcomes. He is a principal investigator of the California Teachers Study cancer epidemiology cohort, and he leads innovative initiatives to improve transparency, efficiency and data-sharing in population sciences.
Huiyan Ma, Ph.D., studies the epidemiology of women’s cancers.
Dr. Palmer’s research interests and effort support preclinical and clinical studies concerning the major obstacles to disease control/cure of hematologic malignancies and successful hematopoietic stem cell transplantation.
Dr. Rockne serves as director of the Division of Mathematical Oncology and Computational Systems Biology, with the goal of translating mathematics, physics and evolution-based research to clinical care.
Andrei S. Rodin, Ph.D., research interests are (i) computational systems biology — both methodology development and application to diverse high-dimensional multiscale biomedical data, and (ii) molecular evolution.
Nagarajan Vaidehi, Ph.D., is a scientist, educator and leader with a career-long commitment to developing computational methods to simulate dynamics of proteins involved in signal transduction pathways and using them for the discovery of next generation drugs with lower side effects. Dr. Vaidehi is
Explore Our Enterprise Leadership Team
Plan Your Visit
Have questions about City of Hope or our appointment process? Visit our appointment information page.
Visiting City of Hope from outside the United States? Let us help make your trip go as smoothly as possible.
With more than 30 locations in Southern California, City of Hope has you covered. Find a location that's convenient for you.